Raptor Pharma (RPTP) Reports Better-Than-Expected Q3 Loss of 6c/Share

Raptor Pharma (NASDAQ: RPTP) reported Q3 EPS of ($0.06), $0.12 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Beike (BEKE) PT Raised to $23 at Morgan Stanley